Seres Therapeutics
MCRB
MCRB
131 hedge funds and large institutions have $535M invested in Seres Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 45 increasing their positions, 54 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
131
Holders Change
-17
Holders Change %
-11.49%
% of All Funds
2.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
45
Reduced
54
Closed
23
Calls
$3.16M
Puts
$1.99M
Net Calls
+$1.17M
Net Calls Change
+$1.54M
Top Buyers
Top Sellers
1 |
Millennium Management
New York
|
$4.2M |
2 |
Goldman Sachs
New York
|
$4.48M |
3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.38M |
4 |
HF
HRT Financial
New York
|
$274K |
5 |
![]()
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$6.69M |